JP2015530889A - 糖尿病患者のための高血糖又は低血糖を示す方法及びシステム - Google Patents

糖尿病患者のための高血糖又は低血糖を示す方法及びシステム Download PDF

Info

Publication number
JP2015530889A
JP2015530889A JP2015523259A JP2015523259A JP2015530889A JP 2015530889 A JP2015530889 A JP 2015530889A JP 2015523259 A JP2015523259 A JP 2015523259A JP 2015523259 A JP2015523259 A JP 2015523259A JP 2015530889 A JP2015530889 A JP 2015530889A
Authority
JP
Japan
Prior art keywords
blood glucose
hyperglycemia
hypoglycemia
value
threshold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015523259A
Other languages
English (en)
Japanese (ja)
Inventor
フランシス ウィルソン ハウウェル
フランシス ウィルソン ハウウェル
ジャニス マクロード
ジャニス マクロード
デイヴィッド ロドバード
デイヴィッド ロドバード
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeScan Inc
Original Assignee
LifeScan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LifeScan Inc filed Critical LifeScan Inc
Publication of JP2015530889A publication Critical patent/JP2015530889A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3569—Range sublocal, e.g. between console and disposable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or Bluetooth®
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • General Business, Economics & Management (AREA)
  • Emergency Medicine (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Business, Economics & Management (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
JP2015523259A 2012-07-19 2013-07-18 糖尿病患者のための高血糖又は低血糖を示す方法及びシステム Pending JP2015530889A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/553,655 US20140024907A1 (en) 2012-07-19 2012-07-19 Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes
US13/553,655 2012-07-19
PCT/US2013/051113 WO2014015160A2 (en) 2012-07-19 2013-07-18 Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes

Publications (1)

Publication Number Publication Date
JP2015530889A true JP2015530889A (ja) 2015-10-29

Family

ID=49947119

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015523259A Pending JP2015530889A (ja) 2012-07-19 2013-07-18 糖尿病患者のための高血糖又は低血糖を示す方法及びシステム

Country Status (13)

Country Link
US (1) US20140024907A1 (https=)
EP (1) EP2874541A4 (https=)
JP (1) JP2015530889A (https=)
KR (1) KR20150036706A (https=)
CN (1) CN104470430A (https=)
AU (1) AU2013292522A1 (https=)
BR (1) BR112015001038A2 (https=)
CA (1) CA2879324A1 (https=)
HK (1) HK1209996A1 (https=)
IN (1) IN2015DN00397A (https=)
RU (1) RU2015105626A (https=)
TW (1) TW201417774A (https=)
WO (1) WO2014015160A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020507397A (ja) * 2017-02-14 2020-03-12 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト 体液中のグルコースレベルを示すグルコースモニタリングデータを分析するための、コンピュータにより実施される方法および携帯型装置、ならびにコンピュータプログラム製品

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014036177A1 (en) 2012-08-30 2014-03-06 Abbott Diabetes Care Inc. Optimizing medication dosage based on analyte sensor data
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
AU2015339576B2 (en) 2014-10-27 2020-02-06 Glytec, Llc Subcutaneous outpatient management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
US11553883B2 (en) * 2015-07-10 2023-01-17 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
WO2017031440A1 (en) 2015-08-20 2017-02-23 Aseko, Inc. Diabetes management therapy advisor
FR3047098B1 (fr) * 2016-01-21 2018-05-25 Voluntis Gestion de l'equilibre glycemique d'un patient diabetique
EP4303884A3 (en) 2016-01-29 2024-04-03 University of Virginia Patent Foundation d/b/a University of Virginia Licensing & Ventures Group Method, system, and computer readable medium for virtualization of a continuous glucose monitoring trace
CN108283486B (zh) * 2017-01-09 2021-04-09 腾讯科技（深圳）有限公司 测量数据的处理方法及装置
TWI668664B (zh) * 2017-01-16 2019-08-11 華廣生技股份有限公司 Method for dynamically analyzing blood sugar level, system thereof and computer program product
CN108335750B (zh) * 2017-01-20 2022-08-09 华广生技股份有限公司 动态分析血糖值的方法、系统与计算机存储介质
US11596330B2 (en) 2017-03-21 2023-03-07 Abbott Diabetes Care Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
USD853583S1 (en) 2017-03-29 2019-07-09 Becton, Dickinson And Company Hand-held device housing
TWI678630B (zh) * 2018-01-16 2019-12-01 中央研究院 非侵入式估測hba1c與血糖值之系統與方法
EP3899982A1 (en) * 2018-12-19 2021-10-27 Sanofi Pattern recognition engine for blood glucose measurements
WO2021011697A1 (en) 2019-07-16 2021-01-21 Beta Bionics, Inc. Blood glucose control system
EP3839963B1 (en) * 2019-12-20 2026-04-15 Digital Diabetes Analytics Sweden AB Diabetes analysis system, and method in relation to the system
WO2022140204A1 (en) * 2020-12-21 2022-06-30 Beta Bionics, Inc. Medicament pumps and control systems thereof
USD1032624S1 (en) 2020-03-10 2024-06-25 Beta Bionics, Inc. Display screen with animated graphical user interface
USD1032623S1 (en) 2020-03-10 2024-06-25 Beta Bionics, Inc. Display screen with animated graphical user interface
US11278661B2 (en) 2020-03-10 2022-03-22 Beta Bionics, Inc. Infusion system and components thereof
CN111653337A (zh) * 2020-05-19 2020-09-11 曲靖师范学院 一种血糖设备控制方法、系统、装置、存储介质、程序
US11594314B2 (en) 2020-12-07 2023-02-28 Beta Bionics, Inc. Modular blood glucose control systems
US20220265143A1 (en) * 2020-12-07 2022-08-25 Beta Bionics, Inc. Ambulatory medicament pumps with selective alarm muting
US20220199218A1 (en) 2020-12-07 2022-06-23 Beta Bionics, Inc. Ambulatory medicament pump with integrated medicament ordering interface
US11497852B2 (en) * 2020-12-21 2022-11-15 Beta Bionics, Inc. Ambulatory medicament device with power saving mode
US12465686B2 (en) 2021-03-25 2025-11-11 Beta Bionics, Inc. Emergency medicament dose control
KR20260034593A (ko) * 2024-09-04 2026-03-11 사회복지법인 삼성생명공익재단 연속혈당측정기를 이용하여 당뇨병 환자를 관리하는 방법, 장치 및 컴퓨터 프로그램

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2404262C (en) * 2000-03-29 2009-03-24 University Of Virginia Patent Foundation Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data
US7824333B2 (en) * 2006-03-31 2010-11-02 Lifescan, Inc. Diabetes management methods and systems
US8758245B2 (en) * 2007-03-20 2014-06-24 Lifescan, Inc. Systems and methods for pattern recognition in diabetes management
US20090240127A1 (en) * 2008-03-20 2009-09-24 Lifescan, Inc. Methods of determining pre or post meal time slots or intervals in diabetes management
EP2354990A1 (en) * 2010-02-03 2011-08-10 Clifton A. Alferness System and method for actively managing type 1 diabetes mellitus on a personalized basis
US8206340B2 (en) * 2010-08-18 2012-06-26 Thuban, Inc. Integrated glucose monitor and insulin injection pen with automatic emergency notification

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020507397A (ja) * 2017-02-14 2020-03-12 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト 体液中のグルコースレベルを示すグルコースモニタリングデータを分析するための、コンピュータにより実施される方法および携帯型装置、ならびにコンピュータプログラム製品
JP7113833B2 (ja) 2017-02-14 2022-08-05 エフ ホフマン－ラ ロッシュ アクチェン ゲゼルシャフト 体液中のグルコースレベルを示すグルコースモニタリングデータを分析するための、コンピュータにより実施される方法および携帯型装置、ならびにコンピュータプログラム製品

Also Published As

Publication number Publication date
WO2014015160A2 (en) 2014-01-23
CA2879324A1 (en) 2014-01-23
TW201417774A (zh) 2014-05-16
RU2015105626A (ru) 2016-09-10
US20140024907A1 (en) 2014-01-23
KR20150036706A (ko) 2015-04-07
BR112015001038A2 (pt) 2017-06-27
WO2014015160A3 (en) 2015-04-30
AU2013292522A1 (en) 2015-03-05
EP2874541A4 (en) 2016-06-08
EP2874541A2 (en) 2015-05-27
HK1209996A1 (en) 2016-04-15
IN2015DN00397A (https=) 2015-06-19
CN104470430A (zh) 2015-03-25

Similar Documents

Publication Publication Date Title
JP2015530889A (ja) 糖尿病患者のための高血糖又は低血糖を示す方法及びシステム
US9402956B2 (en) Handheld diabetes manager with a user interface for displaying a status of an external medical device
JP6461885B2 (ja) 糖尿病管理のための分析物試験方法及びデバイス
JP2015533538A (ja) インスリン注入ポンプコマンドの血糖への影響を示す方法及びシステム
KR101722417B1 (ko) 고혈당 및 저혈당 경향 통지를 갖는 분석물 검사 방법 및 시스템
US20100256047A1 (en) Analyte Measurement and Management Device and Associated Methods
US20100016700A1 (en) Analyte measurement and management device and associated methods
JP2013518324A (ja) 分析物試験方法及びシステム
JP2011523478A (ja) 検体測定及び管理デバイス、並びに関連方法
KR102170071B1 (ko) 확률적 탄수화물 측정들을 갖는 볼러스 계산기
KR20150038189A (ko) 당뇨병이 있는 사람을 위해 다수의 위험 지표를 사용하여 당뇨병을 관리하는 방법 및 시스템
Holubová AUTOMATIC DISCOVERY OF PROBLEMATIC SITUATIONS IN BIOSIGNALS OF PATIENTS WITH DIABETES
HK1188311B (en) Updatability of structured blood glucose tests on handheld diabetes management devices
HK1188311A (en) Updatability of structured blood glucose tests on handheld diabetes management devices
AU2015200504A1 (en) Analyte measurement and management device and associated methods
HK1223154B (en) System and methods for analyzing blood glucose data and quantifying the success for failure of insulin therapy